Zhejiang University

This is an early Phase 1 study to check the safety and find the right dose of an experimental cell therapy called CT0180 for people with advanced liver cancer. The study will enroll 21 patients who have already tried other treatments. Researchers will give patients one or more in…

This early-stage study is testing the safety of a new type of personalized cell therapy called NW-301VT for people with advanced solid tumors that have a specific genetic change (KRAS G12V mutation). About 9 participants will have their own immune cells collected, genetically mod…

This study is testing whether a two-drug combination (blinatumomab and venetoclax) given as maintenance therapy after a stem cell transplant can help prevent leukemia from returning in high-risk patients. The trial involves 24 adults with a specific type of aggressive B-cell leuk…

This study is testing an artificial intelligence (AI) tool designed to help doctors detect liver cancer earlier. Researchers are using CT scans from 10,000 patients with confirmed liver tumors to train and refine the AI model. The goal is to improve the tool's accuracy in identif…